![]() |
Bevacizumab Slows Progression Of Metastatic Breast Cancer But Has No Impact On Surviv
The cancer drug bevacizumab (AvastinĀ®) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers...
More... |
| All times are GMT -7. The time now is 05:39 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021